Clinical Trial Update: A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode [Phase 3]

View source ↗

Summary

This document reports the withdrawal of a Phase 3 trial evaluating aripiprazole for bipolar I disorder with a major depressive episode. The study sponsor is Ots…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Bipolar Disorder | Phase 3 | Status: WITHDRAWN